Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner.

‘There is hope’: Dundee woman shares joy as new MS drug approved for use in Scotland

Katy Wood was "devastated" when she was first diagnosed with MS
Katy Wood was "devastated" when she was first diagnosed with MS

A local woman living with multiple sclerosis (MS) has reacted to the news a new drug to treat the condition has been approved for use on the NHS in Scotland.

MS is a lifelong condition that affects the brain and spinal cord, but can be managed effectively with the use of medication.

Dundonian Katy Wood, 24, was diagnosed with relapsing remitting MS in 2018, during her third year of university.

She remembers: “I was devastated when I was first diagnosed. I was really upset about it.

Katy Wood was diagnosed with MS is 2018.

“At first they didn’t know what was wrong with me, they thought it was just some other demyelinating disease.

“My friend’s mum actually has MS and she told me it sounded similar to what her mum had. I just thought ‘no, it can’t be that’.

“I’d assumed it was an older person’s disease, I had no idea about it. There’s no history of it in my family and I don’t know anyone with it, so it was all brand new to me.”

‘Medication for MS is progressing’

On Monday it was announced that a new drug, Kesimpta, has been approved for use on the NHS in Scotland, meaning MS patients can access the medication for free.

Katy is one of those who could benefit from Kesimpta in the future.

Katy explains: “It’s positive news and shows medication for MS is progressing. There is hope that there’s better medication on the horizon.

Katy has relapsing remitting MS.

“It improves accessibility to medication. It gives people more choice and more control over their MS.

“I think there are so many disease-modifying drugs available, it’s really difficult to know what’s best for you.

“But when there are brand new ones, for me personally I think it’s better because the technology and testing has improved so much.”

Accessing treatment

Access to medication is a huge issue: For those living with relapsing remitting MS, symptoms can be fine one day and can flare up the next.

The new at-home treatment means many will no longer have to go to hospital when their symptoms are bad and won’t have to take time out of work to receive treatment, either.

Katy says: “For me personally, as someone who works every day, that would work way better because I don’t think I could take a full day out of work to get an infusion every month at the hospital.

“Especially if you’re not feeling well after and you maybe need to take a few days off. For someone that’s busier or has a 9-5 job, this fits in way better.”

‘I feel more at ease’

Though the approval of Kesimpta doesn’t currently affect Katy, she’s delighted for the wider MS community and the role it could play in her future treatment.

She continues: “Because it’s for very active MS I wouldn’t be able to go on it at the moment because my MS isn’t that active currently.

Katy Wood.

“But it has made me feel more at ease because if it does get really active, there are other medications for me to go onto.

“For a while I was really worried and they thought my current treatment wasn’t working, so I really panicked there was nothing else for me to go on.

“But there are loads of other options and it’s just finding the one that works for you.”

Already a subscriber? Sign in